Hollsteen
← CrowdStrike

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: −$243M · 10-K 0001535527-20-000006 filed Mar 23, 2020Equity incl. NCI · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2018: −$369M · 10-K 0001535527-20-000006 filed Mar 23, 2020Equity incl. NCI · Q1 FY2019: −$401M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Equity incl. NCI · Q2 FY2019: −$433M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Equity incl. NCI · Q3 FY2019: −$461M · 10-Q 0001535527-19-000011 filed Dec 6, 2019Equity incl. NCI · Q4 FY2019: −$488M · 10-K 0001535527-20-000006 filed Mar 23, 2020Equity incl. NCI · Q1 FY2020: −$485M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Equity incl. NCI · Q2 FY2020: $728M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Equity incl. NCI · Q3 FY2020: $717M · 10-Q 0001535527-19-000011 filed Dec 6, 2019Equity incl. NCI · Q4 FY2020: $743M · 10-K 0001535527-20-000006 filed Mar 23, 2020Equity incl. NCI · Q1 FY2021: $753M · 10-Q 0001535527-20-000012 filed Jun 3, 2020Equity incl. NCI · Q2 FY2021: $792M · 10-Q 0001535527-20-000019 filed Sep 3, 2020Equity incl. NCI · Q3 FY2021: $815M · 10-Q 0001535527-20-000025 filed Dec 3, 2020Equity incl. NCI · Q4 FY2021: $872M · 10-K 0001535527-21-000007 filed Mar 18, 2021Equity incl. NCI · Q1 FY2022: $853M · 10-Q 0001535527-21-000013 filed Jun 4, 2021Equity incl. NCI · Q2 FY2022: $911M · 10-Q 0001535527-21-000022 filed Sep 1, 2021Equity incl. NCI · Q3 FY2022: $960M · 10-Q 0001535527-21-000028 filed Dec 2, 2021Equity incl. NCI · Q4 FY2022: $1.0B · 10-K 0001535527-22-000006 filed Mar 16, 2022Equity incl. NCI · Q1 FY2023: $1.1B · 10-Q 0001535527-22-000012 filed Jun 3, 2022Equity incl. NCI · Q2 FY2023: $1.2B · 10-Q 0001535527-22-000018 filed Aug 31, 2022Equity incl. NCI · Q3 FY2023: $1.3B · 10-Q 0001535527-22-000025 filed Nov 30, 2022Equity incl. NCI · Q4 FY2023: $1.5B · 10-K 0001535527-23-000008 filed Mar 9, 2023Equity incl. NCI · Q1 FY2024: $1.6B · 10-Q 0001535527-23-000014 filed Jun 1, 2023Equity incl. NCI · Q2 FY2024: $1.9B · 10-Q 0001535527-23-000020 filed Aug 31, 2023Equity incl. NCI · Q3 FY2024: $2.1B · 10-Q 0001535527-23-000026 filed Nov 29, 2023Equity incl. NCI · Q4 FY2024: $2.3B · 10-K 0001535527-24-000007 filed Mar 7, 2024Equity incl. NCI · Q1 FY2025: $2.6B · 10-Q 0001535527-24-000013 filed Jun 5, 2024Equity incl. NCI · Q2 FY2025: $2.9B · 10-Q 0001535527-24-000020 filed Aug 29, 2024Equity incl. NCI · Q3 FY2025: $3.1B · 10-Q 0001535527-24-000026 filed Nov 27, 2024Equity incl. NCI · Q4 FY2025: $3.3B · 10-K 0001535527-25-000009 filed Mar 10, 2025Equity incl. NCI · Q1 FY2026: $3.5B · 10-Q 0001535527-25-000019 filed Jun 4, 2025Equity incl. NCI · Q2 FY2026: $3.8B · 10-Q 0001535527-25-000025 filed Aug 28, 2025Equity incl. NCI · Q3 FY2026: $4.1B · 10-Q 0001535527-25-000033 filed Dec 3, 2025Equity incl. NCI · Q4 FY2026: $4.5B · 10-K 0001535527-26-000010 filed Mar 5, 2026Equity incl. NCI · Q1 FY2027: $4.7B · 10-Q 0001535527-26-000025 filed Jun 4, 2026Equity incl. NCI · Q2 FY2027: $5.1B · 10-Q 0001535527-26-000031 filed Aug 27, 2026missing1,3385,140−243Q1 FY2016Q2 FY2027Q3 FY2023
Q3 FY2023
1,338$M
All values (36)
PeriodValue ($M)Status
Q2 FY20275,140reported
Q1 FY20274,675reported
Q4 FY20264,473reported
Q3 FY20264,059reported
Q2 FY20263,795reported
Q1 FY20263,491reported
Q4 FY20253,319reported
Q3 FY20253,096reported
Q2 FY20252,891reported
Q1 FY20252,569reported
Q4 FY20242,337reported
Q3 FY20242,061reported
Q2 FY20241,870reported
Q1 FY20241,634reported
Q4 FY20231,487reported
Q3 FY20231,338reported
Q2 FY20231,243reported
Q1 FY20231,117reported
Q4 FY20221,038reported
Q3 FY2022960reported
Q2 FY2022911reported
Q1 FY2022853reported
Q4 FY2021872reported
Q3 FY2021815reported
Q2 FY2021792reported
Q1 FY2021753reported
Q4 FY2020743reported
Q3 FY2020717reported
Q2 FY2020728reported
Q1 FY2020−485reported
Q4 FY2019−488reported
Q3 FY2019−461reported
Q2 FY2019−433reported
Q1 FY2019−401reported
Q4 FY2018−369reported
Q4 FY2017Noneerror

10 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: equity_total

More metrics for CrowdStrike
Sources & calculation
Value
$1.3B
Period
Q3 FY2023, ended Oct 31, 2022 · as of Oct 31, 2022 (balance as of date, not a sum)
Source
10-Q, filed Nov 30, 2022 · 0001535527-22-000025
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.3BNov 30, 202210-Q 0001535527-22-000025reported · confidence 1. · current